Enzolytics Inc. ENZC OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

13/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Enzolytics Inc. (ENZC) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 11/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

13/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

35/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — ENZC

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-0.04	$0.00	$-5.05M	-
2016	$-0.01	$0.00	$-549.59K	-
2017	$0.00	$190K	$-57.28K	-30.1%
2018	$0.00	$5K	$-1.76M	-35160%
2019	$0.00	$0.00	$920.43K	-
2020	$0.00	$0.00	$-3.48M	-
2021	$0.00	$200K	$-669K	-334.5%
2022	$0.00	$0.00	$-2.94M	-
2023	$0.00	$52.8K	$-2.18M	-4123.1%
2024	$0.00	$0.00	$-394K	-